They will be available as dietary supplements as well as in cereal bars and crackers, the firm added.
The seven botanicals fall under the brand name Avesta. They are: Aspand, Teestar, and Cincata which are aimed at moderating and controlling blood sugar levels.
Bonapure is designed to promote bone growth; Phytossea is said to assist in stopping cartilage degeneration; Smartchol moderates cholesterol level and Xanomax is an antioxidant.
Ingredients and supplements aimed at the diabetic arena have been growing in popularity in recent months.
Managing director Dr Villoo Morawala Patell said: "We strongly believe that science and technology is the way to bring to the people the immense knowledge base of traditional medicine resulting in quality ingredients that add to taste and health needs.
"Avesthagen's goal is to incorporate great-tasting, life-enhancing natural ingredients into the world's lifestyle. We have extensively studied the market and our bionutrition development team has created bioactives with variants that hold tremendous uses for the consumer."
He added that the firm was working on releasing further bioactives in the future.
Avesthagen said that chronic diseases accounted for about 60 percent of the 56.5m deaths in the world.
Development
Avesthagen said it used patented technology to develop the range of bioactives. It used a database, called Adept, that helps match traditional medicine with modern science.
The firm has also developed MetaGrid, which it describes as being able to carry out "comprehensive constituent profiling."
This helps the company create a "metabolic fingerprint" which helps them develop the most appropriate bioactive.
